癌症
癌癥
암증
CHINESE JOURNAL OF CANCER
2002年
6期
582-587
,共6页
郭双平%翟宇强%王文亮%马福成
郭雙平%翟宇彊%王文亮%馬福成
곽쌍평%적우강%왕문량%마복성
抑癌基因PTEN%肾细胞癌%表达
抑癌基因PTEN%腎細胞癌%錶達
억암기인PTEN%신세포암%표체
Tumor suppressor gene PTEN%Primary renal cell carcinoma%Expression
背景与目的:PTEN基因是新发现的一种抑癌基因,定位于人染色体10q23.它的缺失和突变可能构成一个新的信号转导途径,与人类恶性肿瘤的发生普遍相关.资料报道,肾细胞癌有抑癌基因PTEN的缺失和突变.但目前尚未见到关于抑癌基因PTEN在肾细胞癌中表达的研究,本实验研究抑癌基因PTEN在肾细胞癌的表达和生物学意义.方法:应用免疫组织化学SP法检测5例正常肾组织、18例癌旁肾组织和40例肾细胞癌组织中抑癌基因PTEN的表达;分析抑癌基因PTEN的表达与肾细胞癌病理类型、淋巴结转移之间的关系.结果:5例正常肾组织和18例癌旁肾组织均有较强的PTEN蛋白的表达,正常肾组织和癌旁肾组织PTEN蛋白的表达强度、阳性细胞的分布形式无明显差异.肾小管上皮细胞的胞质呈PTEN蛋白阳性,免疫组化染色程度较强,肾小球无PTEN蛋白的表达.抑癌基因PTEN在肾细胞癌中的表达不同于正常肾组织和癌旁肾组织,125%呈PTEN蛋白阴性,175%呈弱阳性,70%呈阳性或强阳性.PTEN蛋白阴性、弱阳性和阳性的肾细胞癌,肾门淋巴结转移率分别为80%,5174%,1071%.PTEN蛋白阴性和弱阳性肾细胞癌的肾门淋巴结转移率与PTEN阳性者比较,差异有显著性(P<005).结论:本实验提示肾细胞癌中存在着抑癌基因PTEN的表达缺失和异常,可能与肾细胞癌的发生、发展有关,抑癌基因PTEN是肾细胞癌的一种新的相关基因.
揹景與目的:PTEN基因是新髮現的一種抑癌基因,定位于人染色體10q23.它的缺失和突變可能構成一箇新的信號轉導途徑,與人類噁性腫瘤的髮生普遍相關.資料報道,腎細胞癌有抑癌基因PTEN的缺失和突變.但目前尚未見到關于抑癌基因PTEN在腎細胞癌中錶達的研究,本實驗研究抑癌基因PTEN在腎細胞癌的錶達和生物學意義.方法:應用免疫組織化學SP法檢測5例正常腎組織、18例癌徬腎組織和40例腎細胞癌組織中抑癌基因PTEN的錶達;分析抑癌基因PTEN的錶達與腎細胞癌病理類型、淋巴結轉移之間的關繫.結果:5例正常腎組織和18例癌徬腎組織均有較彊的PTEN蛋白的錶達,正常腎組織和癌徬腎組織PTEN蛋白的錶達彊度、暘性細胞的分佈形式無明顯差異.腎小管上皮細胞的胞質呈PTEN蛋白暘性,免疫組化染色程度較彊,腎小毬無PTEN蛋白的錶達.抑癌基因PTEN在腎細胞癌中的錶達不同于正常腎組織和癌徬腎組織,125%呈PTEN蛋白陰性,175%呈弱暘性,70%呈暘性或彊暘性.PTEN蛋白陰性、弱暘性和暘性的腎細胞癌,腎門淋巴結轉移率分彆為80%,5174%,1071%.PTEN蛋白陰性和弱暘性腎細胞癌的腎門淋巴結轉移率與PTEN暘性者比較,差異有顯著性(P<005).結論:本實驗提示腎細胞癌中存在著抑癌基因PTEN的錶達缺失和異常,可能與腎細胞癌的髮生、髮展有關,抑癌基因PTEN是腎細胞癌的一種新的相關基因.
배경여목적:PTEN기인시신발현적일충억암기인,정위우인염색체10q23.타적결실화돌변가능구성일개신적신호전도도경,여인류악성종류적발생보편상관.자료보도,신세포암유억암기인PTEN적결실화돌변.단목전상미견도관우억암기인PTEN재신세포암중표체적연구,본실험연구억암기인PTEN재신세포암적표체화생물학의의.방법:응용면역조직화학SP법검측5례정상신조직、18례암방신조직화40례신세포암조직중억암기인PTEN적표체;분석억암기인PTEN적표체여신세포암병리류형、림파결전이지간적관계.결과:5례정상신조직화18례암방신조직균유교강적PTEN단백적표체,정상신조직화암방신조직PTEN단백적표체강도、양성세포적분포형식무명현차이.신소관상피세포적포질정PTEN단백양성,면역조화염색정도교강,신소구무PTEN단백적표체.억암기인PTEN재신세포암중적표체불동우정상신조직화암방신조직,125%정PTEN단백음성,175%정약양성,70%정양성혹강양성.PTEN단백음성、약양성화양성적신세포암,신문림파결전이솔분별위80%,5174%,1071%.PTEN단백음성화약양성신세포암적신문림파결전이솔여PTEN양성자비교,차이유현저성(P<005).결론:본실험제시신세포암중존재착억암기인PTEN적표체결실화이상,가능여신세포암적발생、발전유관,억암기인PTEN시신세포암적일충신적상관기인.
Background & Objective:PTEN gene is a newly discovered tumor suppressor gene,that maps to chromosome 10q23,and of longstanding interest to those studying somatic mutations in human tumors. Mutation and deletion of PTEN gene probably resulted in a new signal transduction pathway related to human malignant tumors. It was reported that PTEN gene mutated and deleted in renal cell carcinoma, however, there was no report concerning its expression in renal cell carcinoma.This study was designed to investigate expression and significance of PTEN gene in primary renal cell carcinoma. Methods: Immunohistochemical peroxidase conjugated streptavidin (SP) method was used to detect expression of PTEN gene in 40 cases of primary renal cell carcinoma, 18 with renal tissues closely adjacent to carcinoma and 5 case of normal renal tissues. The relationship between expression of tumor suppressor gene of PTEN and the percentage of lymph node metastasis of renal cell carcinoma was analyzed. Result: It was showed that PTEN gene was expressed in all 5 case of normal renal tissues and 18 cases of renal tissues closely adjacent to carcinoma. The intensity was relatively strong and it was localized mainly in cytoplasm of epithelium cells of renal tubular. Expression of PTEN in 40 cases of renal cell carcinoma were different, 12.5% were negative , 17.5% were weak positive, and 70% were strong positive. PTEN protein was localized in cytoplasm of carcinoma cells. The percentage of lymph node metastasis of renal cell carcinoma negative or weak positive of PTEN protein was 80% and 51.74% ,respectively. The percentage of lymph node metastasis of renal cell carcinoma positive of PTEN protein was 10.71% , comparing with those of renal cell carcinoma negative or weak positive of PTEN protein, the difference was significant (P< 0.05). Conclusion: This study suggested that PTEN gene was deleted or weakly expressed in primary renal significant cell carcinoma, which is probably related to tumorigenesis and development of renal cell carcinoma.